| Product Code: ETC10639471 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Anti-Cancer Drug Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Anti-Cancer Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Anti-Cancer Drug Market - Industry Life Cycle |
3.4 Israel Anti-Cancer Drug Market - Porter's Five Forces |
3.5 Israel Anti-Cancer Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Anti-Cancer Drug Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.7 Israel Anti-Cancer Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Anti-Cancer Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Growing awareness and adoption of advanced cancer treatments |
4.2.3 Government initiatives and funding to improve cancer care infrastructure |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High cost associated with anti-cancer drugs |
4.3.3 Limited access to cutting-edge cancer treatments in certain regions of Israel |
5 Israel Anti-Cancer Drug Market Trends |
6 Israel Anti-Cancer Drug Market, By Types |
6.1 Israel Anti-Cancer Drug Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Anti-Cancer Drug Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Israel Anti-Cancer Drug Market Revenues & Volume, By Chemotherapy Drugs, 2021 - 2031F |
6.1.4 Israel Anti-Cancer Drug Market Revenues & Volume, By Immunotherapy Drugs, 2021 - 2031F |
6.1.5 Israel Anti-Cancer Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.1.6 Israel Anti-Cancer Drug Market Revenues & Volume, By Biologic Drugs, 2021 - 2031F |
6.2 Israel Anti-Cancer Drug Market, By Therapy |
6.2.1 Overview and Analysis |
6.2.2 Israel Anti-Cancer Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.2.3 Israel Anti-Cancer Drug Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.2.4 Israel Anti-Cancer Drug Market Revenues & Volume, By Hormone Therapy, 2021 - 2031F |
6.2.5 Israel Anti-Cancer Drug Market Revenues & Volume, By Stem Cell Therapy, 2021 - 2031F |
6.3 Israel Anti-Cancer Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Anti-Cancer Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel Anti-Cancer Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Israel Anti-Cancer Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Israel Anti-Cancer Drug Market Revenues & Volume, By Homecare Settings, 2021 - 2031F |
7 Israel Anti-Cancer Drug Market Import-Export Trade Statistics |
7.1 Israel Anti-Cancer Drug Market Export to Major Countries |
7.2 Israel Anti-Cancer Drug Market Imports from Major Countries |
8 Israel Anti-Cancer Drug Market Key Performance Indicators |
8.1 Number of clinical trials for anti-cancer drugs in Israel |
8.2 Adoption rate of personalized medicine in cancer treatment |
8.3 Rate of successful outcomes in cancer therapies |
8.4 Level of investment in research and development for anti-cancer drugs |
8.5 Patient survival rates for different types of cancer in Israel |
9 Israel Anti-Cancer Drug Market - Opportunity Assessment |
9.1 Israel Anti-Cancer Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Anti-Cancer Drug Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.3 Israel Anti-Cancer Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Anti-Cancer Drug Market - Competitive Landscape |
10.1 Israel Anti-Cancer Drug Market Revenue Share, By Companies, 2024 |
10.2 Israel Anti-Cancer Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here